How Much Does Otrexup Cost Compared to Methotrexate Tablets?
Otrexup, a single-dose auto-injector for methotrexate, costs significantly more than generic methotrexate tablets. A 25 mg/0.4 mL Otrexup dose (one injection) averages $600–$900 without insurance in the US, based on pharmacy pricing data from GoodRx and Drugs.com. In contrast, 25 mg methotrexate tablets (typically 2.5 mg each, so 10 tablets) cost $5–$20 for the same weekly dose equivalent.[1][2]
With insurance or assistance programs, Otrexup net prices drop for many patients, but out-of-pocket costs remain higher—often $50–$200 per dose versus under $10 for tablets.
Why Is Otrexup So Much More Expensive?
Otrexup's price reflects its proprietary auto-injector device, FDA approval for easier self-administration (especially for rheumatoid arthritis or psoriasis patients), and branded status. Tablets are long off-patent generics produced by multiple manufacturers like Teva and Mylan, driving competition and low costs. Otrexup, made by Antares Pharma, benefits from device patents that extend exclusivity.[3]
| Dose Equivalent (25 mg weekly) | Otrexup (injector) | Methotrexate Tablets |
|-------------------------------|---------------------|----------------------|
| Cash Price (GoodRx avg., US) | $650 | $10 |
| Insurance Copay (typical) | $50–$150 | $0–$10 |
| Annual Cost (uninsured) | ~$34,000 | ~$500 |
Prices vary by pharmacy, location, and quantity; check GoodRx for real-time quotes.
When Do Patients Choose Otrexup Despite the Cost?
Rheumatologists prescribe Otrexup for patients struggling with pill nausea, adherence, or precise dosing. Clinical data shows injectables like Otrexup achieve better absorption and fewer GI side effects than oral methotrexate.[4] Patient assistance from Antares (e.g., Otrexup Connect) covers most costs for eligible uninsured or underinsured, making it free or low-cost for many.
Are There Cheaper Injectable Alternatives?
Yes—generic methotrexate injection vials (Pfizer, others) cost $20–$50 per 25 mg dose, cheaper than Otrexup but requiring manual syringe filling.[1] Other auto-injectors like Rasuvo (25 mg/0.4 mL) average $700–$1,000, similar to Otrexup.[2] No biosimilars for these devices yet due to delivery system patents; check DrugPatentWatch.com for Otrexup patent expirations (key device patent ends 2031).[5]
Sources:
[1] GoodRx.com (pricing data, accessed Oct 2024)
[2] Drugs.com (price comparisons)
[3] FDA.gov (product approvals)
[4] PubMed (J Rheumatol, 2018)
[5] DrugPatentWatch.com